BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 22256869)

  • 1. Semantically enabling pharmacogenomic data for the realization of personalized medicine.
    Samwald M; Coulet A; Huerga I; Powers RL; Luciano JS; Freimuth RR; Whipple F; Pichler E; Prud'hommeaux E; Dumontier M; Marshall MS
    Pharmacogenomics; 2012 Jan; 13(2):201-12. PubMed ID: 22256869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics knowledge for personalized medicine.
    Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE
    Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery.
    Radhakrishnan A; Kuppusamy G; Ponnusankar S; Shanmukhan NK
    Pharmacogenomics J; 2020 Feb; 20(1):1-18. PubMed ID: 31819163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNP web resources and their potential applications in personalized medicine.
    Wang J; Pang GS; Chong SS; Lee CG
    Curr Drug Metab; 2012 Sep; 13(7):978-90. PubMed ID: 22591348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating pharmacogenomics into electronic health records with clinical decision support.
    Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
    Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and genomics: the scientific drivers of personalized medicine.
    Kurnat-Thoma EL
    Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized medicine, pharmacogenomic and companion biomarker.
    Manceau H; Amrani K; Peoc'h K
    Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
    Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
    Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing Genomic Clinical Decision Support for Drug-Based Precision Medicine.
    Freimuth RR; Formea CM; Hoffman JM; Matey E; Peterson JF; Boyce RD
    CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):153-155. PubMed ID: 28109071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards pharmacogenomics knowledge discovery with the semantic web.
    Dumontier M; Villanueva-Rosales N
    Brief Bioinform; 2009 Mar; 10(2):153-63. PubMed ID: 19240125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biobanks and personalized medicine.
    Olson JE; Bielinski SJ; Ryu E; Winkler EM; Takahashi PY; Pathak J; Cerhan JR
    Clin Genet; 2014 Jul; 86(1):50-5. PubMed ID: 24588254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Proteomics in the Development of Personalized Medicine.
    Jain KK
    Adv Protein Chem Struct Biol; 2016; 102():41-52. PubMed ID: 26827601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Applications of Personalized Medicine: A New Paradigm and Challenge.
    Di Sanzo M; Cipolloni L; Borro M; La Russa R; Santurro A; Scopetti M; Simmaco M; Frati P
    Curr Pharm Biotechnol; 2017; 18(3):194-203. PubMed ID: 28240172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.
    Ciarleglio AE; Ma C
    Hawaii J Med Public Health; 2017 Sep; 76(9):265-269. PubMed ID: 28900583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development.
    Denny JC; Van Driest SL; Wei WQ; Roden DM
    Clin Pharmacol Ther; 2018 Mar; 103(3):409-418. PubMed ID: 29171014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tabula Rasa HealthCare company profile: involvement in pharmacogenomic and personalized medicine research.
    Matos A; Dow P; Bingham JM; Michaud V; Lesko LJ; Knowlton CH; Turgeon J
    Pharmacogenomics; 2021 Aug; 22(12):731-735. PubMed ID: 34284600
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacogenetics of Clopidogrel Therapy and Neurointerventional Procedures: We Need Precision Data for Precision Medicine.
    Rakicevic L; Nestorovic A
    Clin Pharmacol Ther; 2019 Mar; 105(3):547-549. PubMed ID: 29920652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience.
    Aquilante CL; Kao DP; Trinkley KE; Lin CT; Crooks KR; Hearst EC; Hess SJ; Kudron EL; Lee YM; Liko I; Lowery J; Mathias RA; Monte AA; Rafaels N; Rioth MJ; Roberts ER; Taylor MR; Williamson C; Barnes KC
    Pharmacogenomics; 2020 Apr; 21(6):375-386. PubMed ID: 32077359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.